Cronos Group Stock Revenue

CRON Stock  USD 2.08  0.01  0.48%   
Cronos Group fundamentals help investors to digest information that contributes to Cronos' financial success or failures. It also enables traders to predict the movement of Cronos Stock. The fundamental analysis module provides a way to measure Cronos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cronos stock.
Last ReportedProjected for Next Year
Total Revenue87.2 M91.6 M
At this time, Cronos' Total Revenue is very stable compared to the past year. As of the 28th of November 2024, Revenue Per Share is likely to grow to 0.24, while Current Deferred Revenue is likely to drop about 69.9 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cronos Group Company Revenue Analysis

Cronos' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Cronos Revenue

    
  87.24 M  
Most of Cronos' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cronos Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of Cronos

Projected quarterly revenue analysis of Cronos Group provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Cronos match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Cronos' stock price.

Cronos Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Cronos is extremely important. It helps to project a fair market value of Cronos Stock properly, considering its historical fundamentals such as Revenue. Since Cronos' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cronos' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cronos' interrelated accounts and indicators.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Cronos Current Deferred Revenue

Current Deferred Revenue

69,920

At this time, Cronos' Current Deferred Revenue is very stable compared to the past year.
Based on the latest financial disclosure, Cronos Group reported 87.24 M of revenue. This is 98.86% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.08% higher than that of the company.

Cronos Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cronos' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cronos could also be used in its relative valuation, which is a method of valuing Cronos by comparing valuation metrics of similar companies.
Cronos is currently under evaluation in revenue category among its peers.

Cronos Current Valuation Drivers

We derive many important indicators used in calculating different scores of Cronos from analyzing Cronos' financial statements. These drivers represent accounts that assess Cronos' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cronos' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap3.4B2.4B1.5B939.9M795.6M946.8M
Enterprise Value2.2B1.3B578.5M179.2M128.8M122.4M

Cronos ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cronos' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cronos' managers, analysts, and investors.
Environmental
Governance
Social

Cronos Institutional Holders

Institutional Holdings refers to the ownership stake in Cronos that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cronos' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cronos' value.
Shares
Morgan Stanley - Brokerage Accounts2024-06-30
535.6 K
Geode Capital Management, Llc2024-09-30
513.6 K
Citadel Advisors Llc2024-09-30
511.8 K
Kerrisdale Advisers, Llc2024-09-30
458.2 K
Qube Research & Technologies2024-06-30
432.2 K
Swiss National Bank2024-09-30
415.4 K
Intact Investment Management, Inc.2024-09-30
377.9 K
Charles Schwab Investment Management Inc2024-09-30
374.6 K
Goldman Sachs Group Inc2024-06-30
367.4 K
Chescapmanager Llc2024-09-30
M
Vanguard Group Inc2024-09-30
7.5 M

Cronos Fundamentals

About Cronos Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cronos Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cronos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cronos Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Cronos

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cronos Stock

  0.64JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.64LLY Eli Lilly Sell-off TrendPairCorr

Moving against Cronos Stock

  0.55NAMS NewAmsterdam PharmaPairCorr
  0.54BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.5GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out Cronos Piotroski F Score and Cronos Altman Z Score analysis.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
(0.12)
Revenue Per Share
0.267
Quarterly Revenue Growth
0.46
Return On Assets
(0.04)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.